Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 23.93 · gapped above the open, then crossed back over prior close. High/low 24.55 at 8:15 am ET, 23.61 at 11:45 am ET.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“In January 2024, we entered into an exclusive, worldwide license agreement with Immunome, or the Immunome License Agreement, under which Immunome licensed from us ZPC-21 (now known as IM-1021), a preclinical ROR1 ADC with best-in-class potential, and our proprietary ADC platform technology, or the ADC Assets.”
FILING10-K0001725160-26-000014cik 0001725160disclosed by ZNTL
“To date, we have generated our revenue through a Collaboration and Option Agreement, or the Collaboration Agreement, with AbbVie Global Enterprises Ltd., or AbbVie, which terminated in accordance with its terms in July 2025.”
FILING10-K0001193125-26-088172cik 0001472012
“IPR&D expense for the year ended December 31, 2024 primarily related to the write-off of acquired IPR&D assets acquired from Ayala, Bristol-Myers Squibb Company, Zentalis and others that were determined to have no alternative future use.”
FILING10-K0001193125-26-088172cik 0001472012
“We acquired varegacestat from Ayala Pharmaceuticals, Inc., or Ayala, in March 2024.”
FILING10-K0001193125-26-088172cik 0001472012
“In January 2022, Morphimmune entered into a Master License Agreement, or the Purdue License Agreement , with Purdue Research Foundation, or PRF.”
FILING10-K0001193125-26-088172cik 0001472012
Watchlist prices, news filtered to it, and its next report on your desk.
Immunome Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Immunome Inc. has 4 disclosed suppliers and 1 disclosed customer. Each one is named in an SEC filing, either Immunome Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
IMNM (Immunome Inc.) has 4 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: ABBV −0.17%, in healthcare.